Quarterly report [Sections 13 or 15(d)]

Earnings Per Share (Tables)

v3.26.1
Earnings Per Share (Tables)
 3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings Per Share
Shares used in the computation of the Company’s basic and diluted earnings per share are as follows:
(in thousands, except per share data) Three Months Ended March 31,
  2026 2025
Numerator
Net increase (decrease) in net assets resulting from operations $ 42,502  $ 50,337 
Less: Total distributions declared (86,733) (81,384)
Total Earnings (loss), net of total distributions (44,231) (31,047)
Earnings (loss), net of distributions attributable to common shares (44,230) (31,048)
Add: Distributions declared attributable to common shares 85,885  80,616 
Numerator for basic change in net assets per common share 41,655  49,568 
Add: Income impact of assumed conversion of 2028 Convertible Notes 4,079 904
Numerator for diluted change in net assets per common share $ 45,734  $ 50,472 
Denominator
Basic weighted average common shares outstanding 182,760 171,494
Incremental shares from assumed conversion of 2028 Convertible Notes 13,387 3,272
Common shares issuable 674 617
Weighted average common shares outstanding assuming dilution 196,821 175,383
Change in net assets per common share:
Basic $ 0.23  $ 0.29 
Diluted $ 0.23  $ 0.29 
Schedule of Number of Anti-diluted Shares as Calculated Based on Weighted Average Closing Price of Common Stock
The calculation of change in net assets resulting from operations per common share assuming dilution, excludes all anti-dilutive shares. For the three months ended March 31, 2026 and 2025, the number of anti-dilutive shares, as calculated based on the weighted average closing price of the Company’s common stock for the periods, are as follows:
Three Months Ended March 31,
Anti-dilutive Securities 2026 2025
Unvested common stock options 326 1,974
Unvested restricted stock awards 125,767 23